Marcaína Espinal Pesada

Bupivacaine Hydrochloride, the active ingredient in Marcaña Espinal Pesada, is a local anesthetic (amide) presented as a sterile solution for intrathecal use. It provides regional anesthesia for spinal and epidural techniques and is used to control postoperative pain. GNH USA supplies Marcaña Espinal Pesada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Bupivacaine Hydrochloride is employed in the management of pain through spinal or epidural routes.

Spinal anesthesia: produces profound sensory and motor block for surgical procedures performed under spinal technique. Epidural analgesia: provides continuous pain relief during labor, delivery, or postoperative periods. Postoperative pain control: extends analgesia after surgery when administered via neuraxial routes.

Adverse reactions may occur following intrathecal administration of bupivacaine.

Common Side Effects: - Hypotension: decreased blood pressure due to sympathetic blockade. - Bradycardia: slowed heart rate, especially with high spinal levels. - Nausea: gastrointestinal discomfort often related to hypotension. - Pruritus: itching, frequently after epidural use. - Urinary retention: difficulty voiding after spinal block. - Headache: post‑dural puncture headache in some cases.

Serious or Rare Side Effects: - Cardiac arrest: severe conduction disturbances at high plasma concentrations. - Seizures: central nervous system toxicity from excessive dosing. - Respiratory depression: inadequate ventilation due to high spinal block. - Allergic reaction: rash, angioedema, or anaphylaxis. - Neurotoxicity: persistent neurological deficits after intrathecal injection. - Persistent paresthesia: long‑lasting abnormal sensations.

When using bupivacaine intrathecally, clinicians should consider several safety measures.

Assess cardiac function: evaluate baseline heart rate and rhythm before administration. Monitor blood pressure: observe for hypotension and treat promptly. Avoid in known hypersensitivity: do not administer to patients with documented allergy to amide local anesthetics. Use lowest effective dose: titrate to achieve desired block while minimizing systemic exposure. Adjust in hepatic impairment: consider reduced clearance in patients with liver disease. Store at controlled room temperature: keep in original packaging, protect from moisture and light.

Bupivacaine may interact with other medications that affect cardiac conduction or metabolism.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine): can potentiate cardiotoxic effects. - Other local anesthetics: additive toxicity risk. - CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance bradycardia. - Opioids: synergistic respiratory depression. - Sedatives: increased risk of CNS depression.